HEMOGENYX PHARMPLC (Germany) Volatility
| 5HU Stock | EUR 4.14 0.62 13.03% |
HEMOGENYX PHARMPLC is out of control given 3 months investment horizon. HEMOGENYX PHARMPLC holds Efficiency (Sharpe) Ratio of 0.13, which attests that the entity had a 0.13% return per unit of risk over the last 3 months. We were able to interpolate twenty-nine different technical indicators, which can help you to evaluate if expected returns of 16.17% are justified by taking the suggested risk. Use HEMOGENYX PHARMPLC LS 01 Risk Adjusted Performance of 0.1001, semi deviation of 17.26, and Market Risk Adjusted Performance of (0.98) to evaluate company specific risk that cannot be diversified away. Key indicators related to HEMOGENYX PHARMPLC's volatility include:
90 Days Market Risk | Chance Of Distress | 90 Days Economic Sensitivity |
HEMOGENYX PHARMPLC Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of HEMOGENYX daily returns, and it is calculated using variance and standard deviation. We also use HEMOGENYX's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of HEMOGENYX PHARMPLC volatility.
HEMOGENYX |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as HEMOGENYX PHARMPLC can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game as hey may decide to buy additional stocks of HEMOGENYX PHARMPLC at lower prices to lower their average cost per share. Similarly, when the prices of HEMOGENYX PHARMPLC's stock rise, investors can sell out and invest the proceeds in other equities with better opportunities.
Moving against HEMOGENYX Stock
HEMOGENYX PHARMPLC Market Sensitivity And Downside Risk
HEMOGENYX PHARMPLC's beta coefficient measures the volatility of HEMOGENYX stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents HEMOGENYX stock's returns against your selected market. In other words, HEMOGENYX PHARMPLC's beta of -34.31 provides an investor with an approximation of how much risk HEMOGENYX PHARMPLC stock can potentially add to one of your existing portfolios. HEMOGENYX PHARMPLC LS 01 is showing large volatility of returns over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure HEMOGENYX PHARMPLC's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact HEMOGENYX PHARMPLC's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze HEMOGENYX PHARMPLC Demand TrendCheck current 90 days HEMOGENYX PHARMPLC correlation with market (Dow Jones Industrial)HEMOGENYX Beta |
HEMOGENYX standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 127.54 |
It is essential to understand the difference between upside risk (as represented by HEMOGENYX PHARMPLC's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of HEMOGENYX PHARMPLC's daily returns or price. Since the actual investment returns on holding a position in hemogenyx stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in HEMOGENYX PHARMPLC.
HEMOGENYX PHARMPLC Stock Volatility Analysis
Volatility refers to the frequency at which HEMOGENYX PHARMPLC stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with HEMOGENYX PHARMPLC's price changes. Investors will then calculate the volatility of HEMOGENYX PHARMPLC's stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of HEMOGENYX PHARMPLC's volatility:
Historical Volatility
This type of stock volatility measures HEMOGENYX PHARMPLC's fluctuations based on previous trends. It's commonly used to predict HEMOGENYX PHARMPLC's future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for HEMOGENYX PHARMPLC's current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on HEMOGENYX PHARMPLC's to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. HEMOGENYX PHARMPLC Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
HEMOGENYX PHARMPLC Projected Return Density Against Market
Assuming the 90 days horizon HEMOGENYX PHARMPLC LS 01 has a beta of -34.3087 . This suggests as returns on its benchmark rise, returns on holding HEMOGENYX PHARMPLC LS 01 are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, HEMOGENYX PHARMPLC is expected to outperform its benchmark.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to HEMOGENYX PHARMPLC or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that HEMOGENYX PHARMPLC's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a HEMOGENYX stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
HEMOGENYX PHARMPLC LS 01 has an alpha of 35.7745, implying that it can generate a 35.77 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Predicted Return Density |
| Returns |
What Drives a HEMOGENYX PHARMPLC Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.HEMOGENYX PHARMPLC Stock Risk Measures
Assuming the 90 days horizon the coefficient of variation of HEMOGENYX PHARMPLC is 788.79. The daily returns are distributed with a variance of 16265.31 and standard deviation of 127.54. The mean deviation of HEMOGENYX PHARMPLC LS 01 is currently at 37.77. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.72
α | Alpha over Dow Jones | 35.77 | |
β | Beta against Dow Jones | -34.31 | |
σ | Overall volatility | 127.54 | |
Ir | Information ratio | 0.12 |
HEMOGENYX PHARMPLC Stock Return Volatility
HEMOGENYX PHARMPLC historical daily return volatility represents how much of HEMOGENYX PHARMPLC stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company shows 127.5355% volatility of returns over 90 . By contrast, Dow Jones Industrial accepts 0.7915% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About HEMOGENYX PHARMPLC Volatility
Volatility is a rate at which the price of HEMOGENYX PHARMPLC or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of HEMOGENYX PHARMPLC may increase or decrease. In other words, similar to HEMOGENYX's beta indicator, it measures the risk of HEMOGENYX PHARMPLC and helps estimate the fluctuations that may happen in a short period of time. So if prices of HEMOGENYX PHARMPLC fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. The company was incorporated in 2013 and is headquartered in London, the United Kingdom. HEMOGENYX PHARM is traded on Frankfurt Stock Exchange in Germany.
HEMOGENYX PHARMPLC's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on HEMOGENYX Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much HEMOGENYX PHARMPLC's price varies over time.
3 ways to utilize HEMOGENYX PHARMPLC's volatility to invest better
Higher HEMOGENYX PHARMPLC's stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of HEMOGENYX PHARMPLC stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. HEMOGENYX PHARMPLC stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of HEMOGENYX PHARMPLC investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in HEMOGENYX PHARMPLC's stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of HEMOGENYX PHARMPLC's stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
HEMOGENYX PHARMPLC Investment Opportunity
HEMOGENYX PHARMPLC LS 01 has a volatility of 127.54 and is 161.44 times more volatile than Dow Jones Industrial. Compared to the overall equity markets, volatility of historical daily returns of HEMOGENYX PHARMPLC LS 01 is higher than 96 percent of all global equities and portfolios over the last 90 days. You can use HEMOGENYX PHARMPLC LS 01 to protect your portfolios against small market fluctuations. The stock experiences a very speculative upward sentiment. Check odds of HEMOGENYX PHARMPLC to be traded at €3.93 in 90 days.Good diversification
The correlation between HEMOGENYX PHARMPLC LS 01 and DJI is -0.09 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding HEMOGENYX PHARMPLC LS 01 and DJI in the same portfolio, assuming nothing else is changed.
HEMOGENYX PHARMPLC Additional Risk Indicators
The analysis of HEMOGENYX PHARMPLC's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in HEMOGENYX PHARMPLC's investment and either accepting that risk or mitigating it. Along with some common measures of HEMOGENYX PHARMPLC stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.1001 | |||
| Market Risk Adjusted Performance | (0.98) | |||
| Mean Deviation | 69.56 | |||
| Semi Deviation | 17.26 | |||
| Downside Deviation | 23.24 | |||
| Coefficient Of Variation | 804.37 | |||
| Standard Deviation | 271.92 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
HEMOGENYX PHARMPLC Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against HEMOGENYX PHARMPLC as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. HEMOGENYX PHARMPLC's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, HEMOGENYX PHARMPLC's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to HEMOGENYX PHARMPLC LS 01.
Complementary Tools for HEMOGENYX Stock analysis
When running HEMOGENYX PHARMPLC's price analysis, check to measure HEMOGENYX PHARMPLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HEMOGENYX PHARMPLC is operating at the current time. Most of HEMOGENYX PHARMPLC's value examination focuses on studying past and present price action to predict the probability of HEMOGENYX PHARMPLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HEMOGENYX PHARMPLC's price. Additionally, you may evaluate how the addition of HEMOGENYX PHARMPLC to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |